The Armchair Analyst

The Armchair Analyst

5-minute daily updates on the ASX life-sciences sector.

Recent Articles

Don’t sleep on this one: The Avecho (ASX: AVE) Story

Don’t sleep on this one: The Avecho (ASX: AVE) Story

Mar 19, 2026

•

15 min read

Flash update on my day trip to Brisbane

Flash update on my day trip to Brisbane

Mar 18, 2026

•

3 min read

Medical Device Playbook: From FDA Clearance to Commercial Success

Medical Device Playbook: From FDA Clearance to Commercial Success

Mar 17, 2026

•

16 min read

First pick flying, plus my plans for the Armchair Portfolio

First pick flying, plus my plans for the Armchair Portfolio

Mar 16, 2026

•

7 min read

My First Armchair Pick: Tetratherix (ASX: TTX)

My First Armchair Pick: Tetratherix (ASX: TTX)

Mar 16, 2026

•

24 min read

The Curse of the Friday the 13th

The Curse of the Friday the 13th

Mar 13, 2026

•

4 min read

A Nervous Wait for the Immutep Results

A Nervous Wait for the Immutep Results

Mar 12, 2026

•

5 min read

Boom or Bust: The Immutep (ASX: IMM) Trade

Boom or Bust: The Immutep (ASX: IMM) Trade

Mar 11, 2026

•

10 min read

Bloodbath Yesterday. Bounce Today? The Market Seasaw

Bloodbath Yesterday. Bounce Today? The Market Seasaw

Mar 10, 2026

•

9 min read

Trust Your Gut: The Microba (ASX: MAP) Story

Trust Your Gut: The Microba (ASX: MAP) Story

Mar 6, 2026

•

13 min read

The M&A Slide Just Updated Itself: $1.5 billion deal

The M&A Slide Just Updated Itself: $1.5 billion deal

Mar 5, 2026

•

5 min read

Three Shots, One Strategy: The Syntara (ASX: SNT) Story

Three Shots, One Strategy: The Syntara (ASX: SNT) Story

Mar 4, 2026

•

12 min read

...